Q4 2024 · 13F-HR
RTW INVESTMENTS, LPholdings as filed
Filed 2025-02-14 · accession 0001493152-25-006608
$6.61B
Reported value
72
Positions
2024-12-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 558868105 | MDGL | MADRIGAL PHARMACEUTICALS INC | $615.2M | 9.30% | 1,993,687 | Common | SOLE |
| 04016X101 | ARGX | ARGENX SE | $414.2M | 6.26% | 673,497 | Common | SOLE |
| 632307104 | NTRA | NATERA INC | $410.5M | 6.21% | 2,593,323 | Common | SOLE |
| 05464T104 | AXSM | AXSOME THERAPEUTICS INC | $342.8M | 5.18% | 4,051,365 | Common | SOLE |
| 69366J200 | PTCT | PTC THERAPEUTICS INC | $333.7M | 5.05% | 7,393,127 | Common | SOLE |
| 05370A108 | RNAGBP | AVIDITY BIOSCIENCES INC | $230.7M | 3.49% | 7,932,870 | Common | SOLE |
| 77313F106 | RCKT | ROCKET PHARMACEUTICALS INC | $222.3M | 3.36% | 17,687,772 | Common | SOLE |
| G01767105 | ALKS | ALKERMES PLC | $217.4M | 3.29% | 7,557,835 | Common | SOLE |
| 863667101 | SYK | STRYKER CORPORATION | $212.5M | 3.21% | 590,221 | Common | SOLE |
| 74366E102 | PTGX | PROTAGONIST THERAPEUTICS INC | $212.2M | 3.21% | 5,498,545 | Common | SOLE |
| 457669307 | INSM | INSMED INC | $208.1M | 3.15% | 3,014,558 | Common | SOLE |
| 70975L107 | PEN | PENUMBRA INC | $204.8M | 3.10% | 862,450 | Common | SOLE |
| 00973Y108 | AKRO | AKERO THERAPEUTICS INC | $190.8M | 2.89% | 6,859,823 | Common | SOLE |
| 87650L103 | TARS | TARSUS PHARMACEUTICALS INC | $179.2M | 2.71% | 3,236,549 | Common | SOLE |
| N5749R100 | 2GH | MERUS N V | $175.3M | 2.65% | 4,169,393 | Common | SOLE |
| 004225108 | ACAD | ACADIA PHARMACEUTICALS INC | $159.7M | 2.42% | 8,705,501 | Common | SOLE |
| 116794108 | BRKR | BRUKER CORP | $145.4M | 2.20% | 2,481,119 | Common | SOLE |
| 45258D105 | IMCR | IMMUNOCORE HLDGS PLC | $143.7M | 2.17% | 4,869,798 | Common | SOLE |
| 750491102 | RDNT | RADNET INC | $138.2M | 2.09% | 1,978,582 | Common | SOLE |
| 23282W605 | CYTK | CYTOKINETICS INC | $128.0M | 1.94% | 2,721,158 | Common | SOLE |
| 26818M108 | DYN | DYNE THERAPEUTICS INC | $123.0M | 1.86% | 5,218,641 | Common | SOLE |
| 03770N101 | APGE | APOGEE THERAPEUTICS INC | $122.9M | 1.86% | 2,712,097 | Common | SOLE |
| G31249108 | ESTA | ESTABLISHMENT LABS HLDGS INC | $118.4M | 1.79% | 2,569,687 | Common | SOLE |
| 574795100 | MASI | MASIMO CORP | $112.9M | 1.71% | 683,294 | Common | SOLE |
| 925050106 | VRNA | VERONA PHARMA PLC | $84.6M | 1.28% | 1,821,019 | Common | SOLE |
| 00773J202 | SYRE | SPYRE THERAPEUTICS INC | $84.3M | 1.28% | 3,621,996 | Common | SOLE |
| 90400D108 | RARE | ULTRAGENYX PHARMACEUTICAL IN | $82.8M | 1.25% | 1,968,002 | Common | SOLE |
| 379577208 | GMED | GLOBUS MED INC | $80.4M | 1.22% | 972,000 | Common | SOLE |
| 98887Q104 | ZLAB | ZAI LAB LTD | $65.7M | 0.99% | 2,509,119 | Common | SOLE |
| 04335A105 | ARVN | ARVINAS INC | $63.9M | 0.97% | 3,334,308 | Common | SOLE |
| 14179K101 | CRGX | CARGO THERAPEUTICS INC | $59.5M | 0.90% | 4,124,859 | Common | SOLE |
| 282559103 | ETNBGBP | 89BIO INC | $58.5M | 0.88% | 7,478,061 | Common | SOLE |
| 86150R107 | STOK | STOKE THERAPEUTICS INC | $56.5M | 0.85% | 5,123,525 | Common | SOLE |
| 98401F105 | XNCR | XENCOR INC | $55.2M | 0.84% | 2,402,883 | Common | SOLE |
| 156944100 | CGON | CG ONCOLOGY INC | $48.8M | 0.74% | 1,701,216 | Common | SOLE |
| N44445109 | IMTX | IMMATICS N.V | $46.5M | 0.70% | 6,540,540 | Common | SOLE |
| M96088105 | URGN | UROGEN PHARMA LTD | $40.8M | 0.62% | 3,834,794 | Common | SOLE |
| 687604108 | ORKA | ORUKA THERAPEUTICS INC | $37.7M | 0.57% | 1,945,649 | Common | SOLE |
| 68572M106 | OBIO | ORCHESTRA BIOMED HLDGS INC | $32.8M | 0.50% | 8,206,162 | Common | SOLE |
| 64135M105 | NGNE | NEUROGENE INC | $30.9M | 0.47% | 1,350,256 | Common | SOLE |
| 76029N106 | REPL | REPLIMUNE GROUP INC | $25.0M | 0.38% | 2,065,010 | Common | SOLE |
| 52635N103 | LENZ | LENZ THERAPEUTICS INC | $24.9M | 0.38% | 863,389 | Common | SOLE |
| G3855L106 | GHRS | GH RESEARCH PLC | $23.3M | 0.35% | 3,327,129 | Common | SOLE |
| 230031106 | CGEM | CULLINAN THERAPEUTICS INC | $20.8M | 0.31% | 1,705,960 | Common | SOLE |
| 75382E109 | — | RAPT THERAPEUTICS INC | $18.6M | 0.28% | 11,764,000 | Common | SOLE |
| G76279101 | ROIV | ROIVANT SCIENCES LTD | $17.2M | 0.26% | 1,454,273 | Common | SOLE |
| 78667J108 | SG7 | SAGE THERAPEUTICS INC | $16.3M | 0.25% | 3,002,370 | Common | SOLE |
| N90064101 | QURE | UNIQURE NV | $16.0M | 0.24% | 903,625 | Common | SOLE |
| 877619106 | TSHA | TAYSHA GENE THERAPIES INC | $15.0M | 0.23% | 8,672,630 | Common | SOLE |
| 89157D105 | TRML | TOURMALINE BIO INC | $14.9M | 0.23% | 736,681 | Common | SOLE |
| 252828108 | DNTH | DIANTHUS THERAPEUTICS INC | $14.5M | 0.22% | 666,667 | Common | SOLE |
| 221015100 | CRVS | CORVUS PHARMACEUTICALS INC | $14.3M | 0.22% | 2,679,479 | Common | SOLE |
| 45258J102 | IMVT | IMMUNOVANT INC | $13.1M | 0.20% | 530,614 | Common | SOLE |
| 713317105 | PEPG | PEPGEN INC | $12.1M | 0.18% | 3,193,097 | Common | SOLE |
| 20451W101 | CMPS | COMPASS PATHWAYS PLC | $11.7M | 0.18% | 3,098,987 | Common | SOLE |
| Y95308105 | WVE | WAVE LIFE SCIENCES LTD | $11.1M | 0.17% | 900,000 | Common | SOLE |
| G70077105 | PCSC | PERCEPTIVE CAP SOLUTIONS COR | $7.6M | 0.11% | 742,500 | Common | SOLE |
| 30068X103 | XGN | EXAGEN INC | $6.2M | 0.09% | 1,511,866 | Common | SOLE |
| 59935V107 | MIST | MILESTONE PHARMACEUTICALS IN | $5.9M | 0.09% | 2,506,102 | Common | SOLE |
| 45166A102 | IDYA | IDEAYA BIOSCIENCES INC | $5.1M | 0.08% | 200,000 | Common | SOLE |
| 4525EP101 | VTLUSD | IMMUNIC INC | $4.6M | 0.07% | 4,567,717 | Common | SOLE |
| 09077V100 | BIOA | BIOAGE LABS INC | $4.6M | 0.07% | 786,353 | Common | SOLE |
| 15678C102 | CBLL | CERIBELL INC | $3.9M | 0.06% | 150,000 | Common | SOLE |
| 86366E106 | GPCR | STRUCTURE THERAPEUTICS INC | $3.4M | 0.05% | 125,000 | Common | SOLE |
| 00445A100 | — | ACELYRIN INC | $3.1M | 0.05% | 978,310 | Common | SOLE |
| 75901B107 | RGNX | REGENXBIO INC | $2.7M | 0.04% | 350,000 | Common | SOLE |
| 29668H708 | EPIEUR | ESSA PHARMA INC | $2.0M | 0.03% | 1,113,002 | Common | SOLE |
| 04317A107 | ARTV | ARTIVA BIOTHERAPEUTICS INC | $1.5M | 0.02% | 148,844 | Common | SOLE |
| 02008G102 | — | ALLURION TECHNOLOGIES INC | $1.3M | 0.02% | 2,947,551 | Common | SOLE |
| 152309100 | CNTA | CENTESSA PHARMACEUTICALS PLC | $837,500 | 0.01% | 50,000 | Common | SOLE |
| 00534B100 | ADGM | ADAGIO MED HLDGS INC | $219,829 | 0.00% | 209,361 | Common | SOLE |
| 77313F114 | RCKTW | ROCKET PHARMACEUTICALS INC | $12,005 | 0.00% | 350,000 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.